APO Research

APO RESEARCH · REPORT

Pharmacy Benefit Management (PBM)

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

Product & engineering

Understand the product.

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

Selected research

Market Outlook & Growth Opportunities

Global Pharmacy Benefit Management (PBM) Market Outlook and Growth Opportunities 2026

Market perspective

Pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans.

They operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

Three major PBMs maufacturters include Express Scripts, CVS Health, and OptumRx of UnitedHealth Group, which comprise 75% of the market.

Read the full market overview

USA region is enjoying the largest market share of Pharmacy Benefit Management (PBM), with a market share nearly 97%. EU is the second place of Pharmacy Benefit Management (PBM), enjoying market share nearly 2%.

This report provides an overview of the global Pharmacy Benefit Management (PBM) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacy Benefit Management (PBM) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacy Benefit Management (PBM) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacy Benefit Management (PBM) market.

Pharmacy Benefit Management (PBM) Segment by Company

CVS Health (CVS)

Express Scripts

OptumRx (UnitedHealth)

Humana Pharmacy Solutions

Prime Therapeutics

Medimpact Healthcare

Magellan Health

BC/BS

Vidalink

Sea Rainbow

Cachet

Pharmacy Benefit Management (PBM) Segment by Type

Commercial Health Plans

Self-insured Employer Plans

Medicare Part D plans

Federal Employees Health Benefits Program

State Government Employee Plans

Pharmacy Benefit Management (PBM) Segment by Application

Mail-order Pharmacy Services

Non-mail Pharmacy Services

Pharmacy Benefit Management (PBM) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacy Benefit Management (PBM) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacy Benefit Management (PBM) key companies, revenue, market share, and recent developments.

3. To split the Pharmacy Benefit Management (PBM) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacy Benefit Management (PBM) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacy Benefit Management (PBM) significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacy Benefit Management (PBM) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacy Benefit Management (PBM) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacy Benefit Management (PBM) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacy Benefit Management (PBM).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacy Benefit Management (PBM) industry.

Chapter 3: Detailed analysis of Pharmacy Benefit Management (PBM) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacy Benefit Management (PBM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacy Benefit Management (PBM) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacy Benefit Management (PBM) Industry Trends Table 2. Pharmacy Benefit Management (PBM) Industry Drivers Table 3. Pharmacy Benefit Management (PBM) Industry Opportunities and Challenges Table 4. Pharmacy Benefit Management (PBM) Industry Restraints Table 5. Global Pharmacy Benefit Management (PBM) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacy Benefit Management (PBM) Revenue Share by Company (2021-2026) Table 7. Global Pharmacy Benefit Management (PBM) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacy Benefit Management (PBM) Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacy Benefit Management (PBM) Company, Product Type & Application Table 10. Global Pharmacy Benefit Management (PBM) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacy Benefit Management (PBM) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Commercial Health Plans Table 15. Significant Companies of Self-insured Employer Plans Table 16. Significant Companies of Medicare Part D plans Table 17. Significant Companies of Federal Employees Health Benefits Program Table 18. Significant Companies of State Government Employee Plans Table 19. Global Pharmacy Benefit Management (PBM) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmacy Benefit Management (PBM) Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmacy Benefit Management (PBM) Sales Value Share by Type (2021-2026) Table 23. Global Pharmacy Benefit Management (PBM) Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Mail-order Pharmacy Services Table 25. Significant Companies of Non-mail Pharmacy Services Table 26. Global Pharmacy Benefit Management (PBM) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmacy Benefit Management (PBM) Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmacy Benefit Management (PBM) Sales Value Share by Application (2021-2026) Table 30. Global Pharmacy Benefit Management (PBM) Sales Value Share by Application (2027-2032) Table 31. Global Pharmacy Benefit Management (PBM) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmacy Benefit Management (PBM) Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmacy Benefit Management (PBM) Sales Value Share by Region (2021-2026) Table 34. Global Pharmacy Benefit Management (PBM) Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmacy Benefit Management (PBM) Sales Value Share by Region (2027-2032) Table 36. Global Pharmacy Benefit Management (PBM) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmacy Benefit Management (PBM) Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmacy Benefit Management (PBM) Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmacy Benefit Management (PBM) Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmacy Benefit Management (PBM) Sales Value Market Share by Country (2027-2032) Table 41. CVS Health (CVS) Company Information Table 42. CVS Health (CVS) Business Overview Table 43. CVS Health (CVS) Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. CVS Health (CVS) Pharmacy Benefit Management (PBM) Product Portfolio Table 45. CVS Health (CVS) Recent Development Table 46. Express Scripts Company Information Table 47. Express Scripts Business Overview Table 48. Express Scripts Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Express Scripts Pharmacy Benefit Management (PBM) Product Portfolio Table 50. Express Scripts Recent Development Table 51. OptumRx (UnitedHealth) Company Information Table 52. OptumRx (UnitedHealth) Business Overview Table 53. OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Product Portfolio Table 55. OptumRx (UnitedHealth) Recent Development Table 56. Humana Pharmacy Solutions Company Information Table 57. Humana Pharmacy Solutions Business Overview Table 58. Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Product Portfolio Table 60. Humana Pharmacy Solutions Recent Development Table 61. Prime Therapeutics Company Information Table 62. Prime Therapeutics Business Overview Table 63. Prime Therapeutics Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Prime Therapeutics Pharmacy Benefit Management (PBM) Product Portfolio Table 65. Prime Therapeutics Recent Development Table 66. Medimpact Healthcare Company Information Table 67. Medimpact Healthcare Business Overview Table 68. Medimpact Healthcare Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Medimpact Healthcare Pharmacy Benefit Management (PBM) Product Portfolio Table 70. Medimpact Healthcare Recent Development Table 71. Magellan Health Company Information Table 72. Magellan Health Business Overview Table 73. Magellan Health Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Magellan Health Pharmacy Benefit Management (PBM) Product Portfolio Table 75. Magellan Health Recent Development Table 76. BC/BS Company Information Table 77. BC/BS Business Overview Table 78. BC/BS Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BC/BS Pharmacy Benefit Management (PBM) Product Portfolio Table 80. BC/BS Recent Development Table 81. Vidalink Company Information Table 82. Vidalink Business Overview Table 83. Vidalink Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Vidalink Pharmacy Benefit Management (PBM) Product Portfolio Table 85. Vidalink Recent Development Table 86. Sea Rainbow Company Information Table 87. Sea Rainbow Business Overview Table 88. Sea Rainbow Pharmacy Benefit Management (PBM) Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sea Rainbow Pharmacy Benefit Management (PBM) Product Portfolio Table 90. Sea Rainbow Recent Development Table 91. Cachet Company Information Table 92. Cachet Business Overview Table 93. Cachet Pharmacy Benefit Management (PBM) Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 94. Cachet Pharmacy Benefit Management (PBM) Product Portfolio Table 95. Cachet Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Pharmacy Benefit Management (PBM) Product Image Figure 2. Global Pharmacy Benefit Management (PBM) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacy Benefit Management (PBM) Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacy Benefit Management (PBM) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Commercial Health Plans Image Figure 8. Self-insured Employer Plans Image Figure 9. Medicare Part D plans Image Figure 10. Federal Employees Health Benefits Program Image Figure 11. State Government Employee Plans Image Figure 12. Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmacy Benefit Management (PBM) Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmacy Benefit Management (PBM) Sales Value Share by Type (2021-2032) Figure 15. Mail-order Pharmacy Services Image Figure 16. Non-mail Pharmacy Services Image Figure 17. Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmacy Benefit Management (PBM) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmacy Benefit Management (PBM) Sales Value Share by Application (2021-2032) Figure 20. Global Pharmacy Benefit Management (PBM) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmacy Benefit Management (PBM) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmacy Benefit Management (PBM) Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmacy Benefit Management (PBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmacy Benefit Management (PBM) Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmacy Benefit Management (PBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmacy Benefit Management (PBM) Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmacy Benefit Management (PBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Commercial Health Plans
  • Self-insured Employer Plans
  • Medicare Part D plans
  • Federal Employees Health Benefits Program
  • State Government Employee Plans
Applications
  • Mail-order Pharmacy Services
  • Non-mail Pharmacy Services
Companies covered
  • CVS Health (CVS)
  • Express Scripts
  • OptumRx (UnitedHealth)
  • Humana Pharmacy Solutions
  • Prime Therapeutics
  • Medimpact Healthcare
  • Magellan Health
  • BC/BS
  • Vidalink
  • Sea Rainbow
  • Cachet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacy Benefit Management (PBM) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacy Benefit Management (PBM) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacy Benefit Management (PBM) Market Dynamics
  1. 2.1 Pharmacy Benefit Management (PBM) Industry Trends
  2. 2.2 Pharmacy Benefit Management (PBM) Industry Drivers
  3. 2.3 Pharmacy Benefit Management (PBM) Industry Opportunities and Challenges
  4. 2.4 Pharmacy Benefit Management (PBM) Industry Restraints
3 Pharmacy Benefit Management (PBM) Market by Company
  1. 3.1 Global Pharmacy Benefit Management (PBM) Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacy Benefit Management (PBM) Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacy Benefit Management (PBM) Company Ranking (2024-2026)
  4. 3.4 Global Pharmacy Benefit Management (PBM) Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacy Benefit Management (PBM) Company Product Type and Application
  6. 3.6 Global Pharmacy Benefit Management (PBM) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacy Benefit Management (PBM) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacy Benefit Management (PBM) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacy Benefit Management (PBM) Market by Type
  1. 4.1 Pharmacy Benefit Management (PBM) Type Introduction
  2. 4.1.1 Commercial Health Plans
  3. 4.1.2 Self-insured Employer Plans
  4. 4.1.3 Medicare Part D plans
  5. 4.1.4 Federal Employees Health Benefits Program
  6. 4.1.5 State Government Employee Plans
  7. 4.2 Global Pharmacy Benefit Management (PBM) Sales Value by Type
  8. 4.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmacy Benefit Management (PBM) Sales Value Share by Type (2021-2032)
5 Pharmacy Benefit Management (PBM) Market by Application
  1. 5.1 Pharmacy Benefit Management (PBM) Application Introduction
  2. 5.1.1 Mail-order Pharmacy Services
  3. 5.1.2 Non-mail Pharmacy Services
  4. 5.2 Global Pharmacy Benefit Management (PBM) Sales Value by Application
  5. 5.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmacy Benefit Management (PBM) Sales Value Share by Application (2021-2032)
6 Pharmacy Benefit Management (PBM) Regional Value Analysis
  1. 6.1 Global Pharmacy Benefit Management (PBM) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacy Benefit Management (PBM) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacy Benefit Management (PBM) Sales Value Share by Country, 2025 VS 2032
7 Pharmacy Benefit Management (PBM) Country-level Value Analysis
  1. 7.1 Global Pharmacy Benefit Management (PBM) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacy Benefit Management (PBM) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacy Benefit Management (PBM) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacy Benefit Management (PBM) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CVS Health (CVS)
  2. 8.1.1 CVS Health (CVS) Company Information
  3. 8.1.2 CVS Health (CVS) Business Overview
  4. 8.1.3 CVS Health (CVS) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CVS Health (CVS) Pharmacy Benefit Management (PBM) Product Portfolio
  6. 8.1.5 CVS Health (CVS) Recent Developments
  7. 8.2 Express Scripts
  8. 8.2.1 Express Scripts Company Information
  9. 8.2.2 Express Scripts Business Overview
  10. 8.2.3 Express Scripts Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Express Scripts Pharmacy Benefit Management (PBM) Product Portfolio
  12. 8.2.5 Express Scripts Recent Developments
  13. 8.3 OptumRx (UnitedHealth)
  14. 8.3.1 OptumRx (UnitedHealth) Company Information
  15. 8.3.2 OptumRx (UnitedHealth) Business Overview
  16. 8.3.3 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 OptumRx (UnitedHealth) Pharmacy Benefit Management (PBM) Product Portfolio
  18. 8.3.5 OptumRx (UnitedHealth) Recent Developments
  19. 8.4 Humana Pharmacy Solutions
  20. 8.4.1 Humana Pharmacy Solutions Company Information
  21. 8.4.2 Humana Pharmacy Solutions Business Overview
  22. 8.4.3 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Humana Pharmacy Solutions Pharmacy Benefit Management (PBM) Product Portfolio
  24. 8.4.5 Humana Pharmacy Solutions Recent Developments
  25. 8.5 Prime Therapeutics
  26. 8.5.1 Prime Therapeutics Company Information
  27. 8.5.2 Prime Therapeutics Business Overview
  28. 8.5.3 Prime Therapeutics Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Prime Therapeutics Pharmacy Benefit Management (PBM) Product Portfolio
  30. 8.5.5 Prime Therapeutics Recent Developments
  31. 8.6 Medimpact Healthcare
  32. 8.6.1 Medimpact Healthcare Company Information
  33. 8.6.2 Medimpact Healthcare Business Overview
  34. 8.6.3 Medimpact Healthcare Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medimpact Healthcare Pharmacy Benefit Management (PBM) Product Portfolio
  36. 8.6.5 Medimpact Healthcare Recent Developments
  37. 8.7 Magellan Health
  38. 8.7.1 Magellan Health Company Information
  39. 8.7.2 Magellan Health Business Overview
  40. 8.7.3 Magellan Health Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Magellan Health Pharmacy Benefit Management (PBM) Product Portfolio
  42. 8.7.5 Magellan Health Recent Developments
  43. 8.8 BC/BS
  44. 8.8.1 BC/BS Company Information
  45. 8.8.2 BC/BS Business Overview
  46. 8.8.3 BC/BS Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BC/BS Pharmacy Benefit Management (PBM) Product Portfolio
  48. 8.8.5 BC/BS Recent Developments
  49. 8.9 Vidalink
  50. 8.9.1 Vidalink Company Information
  51. 8.9.2 Vidalink Business Overview
  52. 8.9.3 Vidalink Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vidalink Pharmacy Benefit Management (PBM) Product Portfolio
  54. 8.9.5 Vidalink Recent Developments
  55. 8.10 Sea Rainbow
  56. 8.10.1 Sea Rainbow Company Information
  57. 8.10.2 Sea Rainbow Business Overview
  58. 8.10.3 Sea Rainbow Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sea Rainbow Pharmacy Benefit Management (PBM) Product Portfolio
  60. 8.10.5 Sea Rainbow Recent Developments
  61. 8.11 Cachet
  62. 8.11.1 Cachet Company Information
  63. 8.11.2 Cachet Business Overview
  64. 8.11.3 Cachet Pharmacy Benefit Management (PBM) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cachet Pharmacy Benefit Management (PBM) Product Portfolio
  66. 8.11.5 Cachet Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research